TP53 and pancreatic neoplasm: The phenotypical effects of mutant TP53 in pancreatic cancer were demonstrated by Weissmueller et al. in an in vitro analysis, which showed that the sustained expression of the mutant TP53 allele is necessary to maintain the invasive phenotype of PDAC [46].